MMSI
Merit Medical Systems, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.9% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 81.11K | $6.98M | n/a | n/a |
| Q2 2026 | 119 | +2 | 41.26M | $2.86B | +12 | −9 |
| Q1 2026 | 119 | +2 | 38.80M | $2.68B | +10 | −9 |
| Q4 2025 | 117 | -1 | 45.00M | $3.97B | +2 | −2 |
| Q3 2025 | 21 | +1 | 28.60M | $2.38B | +1 | −1 |
| Q2 2025 | 18 | 0 | 26.61M | $2.49B | +1 | −1 |
| Q1 2025 | 15 | -1 | 7.60M | $802.99M | +1 | −2 |
| Q4 2024 | 16 | 0 | 7.36M | $712.26M | +2 | −2 |
| Q3 2024 | 15 | +1 | 4.73M | $467.42M | +1 | n/a |
| Q2 2024 | 14 | n/a | 5.63M | $483.63M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 2.29M | n/a | $221.79M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 1.36M | 0.0% | $131.30M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 772.88K | -0.4% | $74.75M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 698.59K | +1547.1% | $67.57M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 688.98K | -6.2% | $66.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 298.26K | -15.7% | $28.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 278.84K | -24.8% | $26.97M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 250.00K | 0.0% | $24.18M | 0.0% | Held | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 225.64K | Nieuw | $21.82M | 0.0% | New | 1 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 224.18K | +1.1% | $21.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 108.71K | +16.5% | $10.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 74.29K | +413.7% | $7.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Millennium Management ✦ | 66.28K | -51.3% | $6.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 15.25K | +15.1% | $1.47M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 15 | Bridgewater Associates ✦ | 6.63K | -30.8% | $641,737 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 5.00K | Nieuw | $483,697 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Wellington Management | $21.82M | 0.0% |
| Arrowstreet Capital | $483,697 | 0.0% |
Verlaten
| Point72 Asset Management | $34.38M | was 0.1% |
| Gotham Asset Management | $787,972 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 398 houders, 58.87M aandelen, $3.96B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 7.50K aand · $678,360
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie